Study identifies possible link between mitochondrial proteins and MG
Some proteins inside mitochondria may raise the risk of myasthenia gravis (MG), while others may help protect against it.
News
-
-
New research indicates MG is on the rise in the US
New data show increasing incidence and prevalence of myasthenia gravis in U.S. adults, with high exacerbation rates.
-
New study shows benefits of structured exercise for people with MG
Physical and respiratory rehabilitation therapy is associated with significant benefits for patients with myasthenia gravis (MG).
-
People with myasthenia gravis less likely to engage socially with others
To improve social participation, various life-limiting disease manifestations must first be adequately addressed.
-
Study explores how MG disrupts sleep, daily rhythms and mental health
Besides causing muscle weakness, myasthenia gravis (MG) also affects natural rhythms in sleep and other daily activities.
-
Having multiple autoimmune diseases does not make MG worse, study finds
Concurrent autoimmune diseases do not worsen outcomes in patients with MG.
-
Patients with MG more likely to experience anxiety and depression
Patients with MG are more likely than the general population to be diagnosed with depression and anxiety, which may worsen symptoms.
-
Sleep disturbances prevalent among patients with MG
Sleep disturbances are an often overlooked and but important aspect of care among patients with myasthenia gravis.
-
Thymectomy likely beneficial in many patients with late-onset MG
New evidence suggests that thymectomy can result in clinical remission in older patients with a particular subtype of MG.
-
New antibody-targeting drug may hold promise in MG
Researchers identified a novel drug that can break down antibodies against the acetylcholine receptor, which are prevalent in people with MG.
